VECT
NASDAQ
$16.85
VectivBio Holding AG (VECT)
VectivBio Holding AG, a clinical-stage biopharmaceutical company, focuses on the discovery, development and commercialization of treatments for rare conditions. The company is headquartered in Basel, Switzerland.
Sector:
Healthcare
Industry:
Pharmaceuticals
Target: $18.33 (+8.78%)
Market Cap
$744M
Free Cash Flow Yield
1.76%
Price Chart
Valuation
Market Cap$744M
P/S21.08
P/B3.62
Profitability
Total Revenue (TTM)$676K
Gross Profit (TTM)$27M
EBITDA-$72M
Operating Margin-294.5%
EPS-$3.07
Financial Health
Debt-to-Equity4.9%
Free Cash Flow Yield1.76%